Renal abnormalities in beckwith-wiedemann syndrome are associated with 11p15.5 uniparental disomy.

Beckwith-Wiedemann syndrome (BWS) is a somatic overgrowth syndrome characterized by a variable incidence of congenital anomalies, including hemihyperplasia and renal malformations. BWS is associated with disruption of genomic imprinting and/or mutations in one or more genes encoded on 11p15.5, including CDKN1C (p57(KIP2)). It was hypothesized that genotypic and epigenotypic abnormalities of the 11p15.5 region affecting CDKN1C were associated with renal abnormalities. Medical records for 159 individuals with BWS were reviewed. All underwent at least one abdominal ultrasonographic evaluation. Testing for paternal uniparental disomy (UPD) at 11p15.5, CDKN1C mutations, and imprinting defects at KvDMR1 was performed for 96, 32, and 47 patients, respectively. Of the 159 patients, 67 (42%) exhibited renal abnormalities, mainly nephromegaly (25%), collecting system abnormalities (11%), and renal cysts (10.5%). The frequency of renal lesions among patients who were tested for genetic abnormalities did not differ from that among patients who were not tested. Paternal UPD was demonstrated in 22 of 96 cases (23%), CDKN1C mutations in eight of 32 cases (25%), and KvDMR1 imprinting defects in 21 of 47 cases (45%). The 22 UPD-positive patients exhibited a significantly higher incidence of renal abnormalities (P = 0.0026). Surprisingly, the eight patients with CDKN1C mutations exhibited no significant increase in the incidence of renal lesions (P = 0.29). Imprinting defects at KvDMR1, which might downregulate CDKN1C, were also not associated with a significant difference in the incidence of renal disease. Whereas UPD at 11p15.5 in BWS was associated with a higher incidence of renal abnormalities, mutations at CDKN1C and KvDMR1 imprinting defects were not, suggesting that imprinted genes on 11p15.5 other than CDKN1C are critical for renal development.

[1]  H. Wiedemann.  Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome , 1983, European Journal of Pediatrics.

[2]  R. Weksberg,et al.  Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. , 2001, Human molecular genetics.

[3]  R. Weksberg,et al.  Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations. , 2001, Genomics.

[4]  M. Meguro,et al.  Targeted disruption of the human LIT1 locus defines a putative imprinting control element playing an essential role in Beckwith-Wiedemann syndrome. , 2000, Human molecular genetics.

[5]  W. Reik,et al.  Beckwith-Wiedemann syndrome: imprinting in clusters revisited. , 2000, The Journal of clinical investigation.

[6]  M. Cleary,et al.  Oppositely imprinted genes p57(Kip2) and igf2 interact in a mouse model for Beckwith-Wiedemann syndrome. , 1999, Genes & development.

[7]  D. J. Driscoll,et al.  A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. Reik,et al.  Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation , 1999, Journal of Medical Genetics.

[9]  M. Cohen.  Overgrowth syndromes: an update. , 1999, Advances in pediatrics.

[10]  C. Barnewolt,et al.  Renal findings on radiological followup of patients with Beckwith-Wiedemann syndrome. , 1999, The Journal of urology.

[11]  W. Reik,et al.  Analysis of germline CDKN 1 C ( p 57 KIP 2 ) mutations in familial and sporadic Beckwith-Wiedemann syndrome ( BWS ) provides a novel genotype-phenotype correlation , 1999 .

[12]  P. Choyke,et al.  Nonmalignant renal disease in pediatric patients with Beckwith-Wiedemann syndrome. , 1998, AJR. American journal of roentgenology.

[13]  P. Choyke,et al.  Nephromegaly in infancy and early childhood: a risk factor for Wilms tumor in Beckwith-Wiedemann syndrome. , 1998, The Journal of pediatrics.

[14]  W. Reik,et al.  Transactivation of Igf2 in a mouse model of Beckwith–Wiedemann syndrome , 1997, Nature.

[15]  L. Gaunt,et al.  Paternally inherited duplications of 11p15.5 and Beckwith-Wiedemann syndrome. , 1997, Journal of medical genetics.

[16]  M. Vazquez,et al.  The Beckwith-Wiedemann syndrome phenotype and the risk of cancer. , 1997, Medical and pediatric oncology.

[17]  S. Elledge,et al.  Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome , 1997, Nature.

[18]  A. Feinberg,et al.  Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  I. Temple,et al.  Clinical features and natural history of Beckwith‐Wiedemann syndrome: presentation of 74 new cases , 1994, Clinical genetics.

[20]  W. Reik,et al.  Allelic methylation of H19 and IGF2 in the Beckwith-Wiedemann syndrome. , 1994, Human molecular genetics.

[21]  R. Weksberg,et al.  Disruption of insulin–like growth factor 2 imprinting in Beckwith–Wiedemann syndrome , 1993, Nature genetics.

[22]  J. Toulouse,et al.  Hepatic hemangioendotheliomas, placental chorioangiomas, and dysmorphic kidneys in Beckwith-Wiedemann syndrome. , 1992, Pediatric pathology.

[23]  C. Junien,et al.  Uniparental paternal disomy in a genetic cancer-predisposing syndrome , 1991, Nature.

[24]  M. Mclachlan,et al.  Aging and simple cysts of the kidney. , 1981, The British journal of radiology.

[25]  Nan Faion T. Wu,et al.  The Beckwith-Wiedemann Syndrome , 1974, Clinical pediatrics.